Sökning: onr:"swepub:oai:lup.lub.lu.se:d3b7a2df-092e-4d33-9a2f-d8ab2b62be78" >
A Novel Blood Test ...
A Novel Blood Test for the Early Detection of Alzheimer's Disease
-
Rye, Phil D. (författare)
-
Booij, Birgitte Boonstra (författare)
-
Grave, Gisle (författare)
-
visa fler...
-
Lindahl, Torbjorn (författare)
-
Kristiansen, Lena (författare)
-
Andersen, Hilde-Marie (författare)
-
Horndalsveen, Peter O. (författare)
-
Nygaard, Harald A. (författare)
-
Naik, Mala (författare)
-
Hoprekstad, Dagne (författare)
-
Wetterberg, Peter (författare)
-
- Nilsson, Christer (författare)
- Lund University,Lunds universitet,Psykiatri, Lund,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Psychiatry (Lund),Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine
-
- Aarsland, Dag (författare)
- Karolinska Institutet
-
Sharma, Praveen (författare)
-
Lonneborg, Anders (författare)
-
visa färre...
-
(creator_code:org_t)
- 2011
- 2011
- Engelska.
-
Ingår i: Journal of Alzheimer's Disease. - 1387-2877 .- 1875-8908. ; 23:1, s. 121-129
- Relaterad länk:
-
http://dx.doi.org/10...
-
visa fler...
-
https://lup.lub.lu.s...
-
https://doi.org/10.3...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Despite a variety of testing approaches, it is often difficult to make an accurate diagnosis of Alzheimer's disease (AD), especially at an early stage of the disease. Diagnosis is based on clinical criteria as well as exclusion of other causes of dementia but a definitive diagnosis can only be made at autopsy. We have investigated the diagnostic value of a 96-gene expression array for detection of early AD. Gene expression analysis was performed on blood RNA from a cohort of 203 probable AD and 209 cognitively healthy age matched controls. A disease classification algorithm was developed on samples from 208 individuals (AD = 103; controls = 105) and was validated in two steps using an independent initial test set (n = 74; AD= 32; controls = 42) and another second test set (n = 130; AD= 68; controls = 62). In the initial analysis, diagnostic accuracy was 71.6 +/- 10.3%, with sensitivity 71.9 +/- 15.6% and specificity 71.4 +/- 13.7%. Essentially the same level of agreement was achieved in the two independent test sets. High agreement (24/30; 80%) between algorithm prediction and subjects with available cerebrospinal fluid biomarker was found. Assuming a clinical accuracy of 80%, calculations indicate that the agreement with underlying true pathology is in the range 85%-90%. These findings suggest that the gene expression blood test can aid in the diagnosis of mild to moderate AD, but further studies are needed to confirm these findings.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Neurologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Neurology (hsv//eng)
Nyckelord
- Alzheimer's disease
- biomarker
- blood
- diagnostic test
- gene
- expression
- RNA
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Rye, Phil D.
-
Booij, Birgitte ...
-
Grave, Gisle
-
Lindahl, Torbjor ...
-
Kristiansen, Len ...
-
Andersen, Hilde- ...
-
visa fler...
-
Horndalsveen, Pe ...
-
Nygaard, Harald ...
-
Naik, Mala
-
Hoprekstad, Dagn ...
-
Wetterberg, Pete ...
-
Nilsson, Christe ...
-
Aarsland, Dag
-
Sharma, Praveen
-
Lonneborg, Ander ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Neurologi
- Artiklar i publikationen
-
Journal of Alzhe ...
- Av lärosätet
-
Lunds universitet
-
Karolinska Institutet